Tri Locum Partners LP Curis Inc Transaction History
Tri Locum Partners LP
- $374 Million
- Q3 2024
About CURIS INC
- Ticker CRIS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 91,814,704
- Market Cap $332M
- Description
- Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...